Home › NDC Lookup › RxCUI directory › RxCUI 1858970

{7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release O... — RxCUI 1858970

RxNorm drug concept · Generic pack
RxCUI 1858970 Generic pack · GPCK ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1858970
Official name{7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 21 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 7 MG Extended Release Oral Capsule) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asmemantine and donepezil hydrochlorides titration pack; memantine and donepezil hydrochlorides titration pack 7 MG/10 MG (7), 14 MG/10 MG (7), 21 MG/10 MG (7), 28 MG/10 MG (7) Oral Capsule 28 Day Pack
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)975 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Memantine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Memantine treats moderate to severe dementia of the Alzheimer’s type. It helps manage symptoms, but it has not been shown to prevent or slow the underlying nerve damage.
  • Take it by mouth as your prescriber directs. The dose usually starts low and goes up over several weeks. Tablets and oral solution can be taken with or without food. If you miss a...
  • The most common are dizziness, headache, confusion and constipation. Tell your doctor if they bother you or don’t settle. Seek help quickly for a seizure, a severe skin reaction, u...
  • Many people take it with donepezil, which showed no interaction in studies. Be careful with amantadine, ketamine and dextromethorphan, and with sodium bicarbonate or carbonic anhyd...
📖 Read our full Memantine guide →

🕸️ Concept Web — How {7 (24 HR donepezil hydrochloride 10 MG / memant... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 14 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 21 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG Extended Release Oral Capsule) / 7 (24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 7 MG Extended Release Oral Capsule) } Pack RxCUI 1858970

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Donepezil 135447
    • Memantine 6719
    • Donepezil / memantine 1430990
    • Donepezil hydrochloride 236559
    • Memantine hydrochloride 236685
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Namzaric 1602583
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Donepezil / memantine Extended Release Oral Capsule 1599802
    • Donepezil hydrochloride / memantine hydrochloride Extended Release Oral Capsule 2649304
    • Donepezil / memantine Oral Product 1599800
    • Donepezil / memantine Pill 1599801
    • Donepezil hydrochloride / memantine hydrochloride Oral Product 2660520
    • Donepezil hydrochloride / memantine hydrochloride Pill 2662557
    • Donepezil / memantine Extended Release Oral Capsule [Namzaric] 1602585
    • Donepezil hydrochloride / memantine hydrochloride Extended Release Oral Capsule [Namzaric] 2657352
    • +5 more in this family
  4. Clinical & branded drugs 17

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 23 of 37 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1858970 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00456-1207-30 30 CAPSULE in 1 BOTTLE (0456-1207-30) Namzaric Allergan, Inc. 2016-07-18
00456-1214-30 30 CAPSULE in 1 BOTTLE (0456-1214-30) Namzaric Allergan, Inc. 2014-12-24
00456-1221-30 30 CAPSULE in 1 BOTTLE (0456-1221-30) Namzaric Allergan, Inc. 2016-07-18
00456-1228-30 30 CAPSULE in 1 BOTTLE (0456-1228-30) Namzaric Allergan, Inc. 2014-12-24
Observed labelers: Allergan, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.